Integrated Health Systems is seeking volunteers with mild to moderate Alzheimer’s for a groundbreaking study using a telomerase induction therapy. Applicants will need to have already been diagnosed to qualify and will need to send their medical records to IHS before scheduling a complimentary consultation appointment.
Qualifications for Study Admission (Inclusion Criteria):
At this point an Alzheimer’s cure looks remote. Decades of work by pharmaceutical companies has yielded very disappointing results and, at this time, there are no effective ways to manage, much less reverse, its progression. Alzheimer’s prevention is a growing area of interest, with promises of a vaccine coming in the near future. However, as the researchers behind the vaccine have warned, it has only passed muster with mice, meaning approval for humans is years away. In the meantime nearly 800 diagnoses are made every day. Some common Alzheimer’s symptoms include:
There are some lifestyle adjustments that can be made to reduce your risk, but the single largest Alzheimer’s risk factor is aging. Telomere shortening is one of the major hallmarks of aging, one of the processes that causes the functioning of your cells and, ultimately, your brain and body, to decline over time. This is what makes Integrated Health System’s telomerase induction gene therapy a potential game changer in the treatment of neurodegenerative diseases.
If you or a loved one are interested in receiving a free $62,000 therapy, please fill out the form below